Open AccessMultiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men
Author(s) -
Michael Kongnyuy,
Mohummad Minhaj Siddiqui,
Arvin George,
Akhil Muthigi,
Abhinav Sidana,
Mahir Maruf,
Barış Türkbey,
Peter L. Choyke,
Bradford J. Wood,
Peter A. Pinto
Publication year - 2017
Publication title -
prostate cancer and prostatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2
H-Index - 64
eISSN - 1476-5608
pISSN - 1365-7852
DOI - 10.1038/pcan.2017.21
Subject(s) - medicine , biopsy , cohort , magnetic resonance imaging , prostate cancer , population , radiology , cancer , environmental health
Analysis of systematic 12-core biopsies (SBx) has shown that African-American (AA) men tend to harbor higher risk prostate cancer (PCa) at presentation relative to other races. Multiparametric magnetic resonance imaging (mpMRI) and MRI-ultrasound fusion-guided biopsy (FBx) have been shown to diagnose more intermediate- and high-risk PCa in the general population; however, the efficacy in AA remains largely uncharacterized. We aim to evaluate the utility of FBx in an AA patient cohort.